Evaluate the Relationship of Bone Remodeling Markers for Skeletal Complications in Metastatic Breast Cancer Patients

NCT00912938 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

237

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Breast Cancer

Interventions

DRUG: zoledronic acid

Sponsor

Korean Breast Cancer Study Group